COPALIA

This brand name is authorized in Austria, Croatia, Estonia, Germany, Ireland, Lithuania, Netherlands, Poland, South Africa, Spain.

Active ingredients

The drug COPALIA contains a combination of these active pharmaceutical ingredients (APIs):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
2	Valsartan UNII 80M03YXJ7I - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COPALIA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DB01	Valsartan and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	13509780, 13509797, 14398934, 14398963, 15265922, 15265939, 15318423, 15318446, 15816173, 15816196, 16020737, 16020766
EE	Ravimiamet	1278794, 1278806, 1278817, 1278828, 1278839, 1278840, 1278851, 1278862, 1278873, 1278884, 1278895, 1278907, 1278918, 1278929, 1278930, 1278941, 1278952, 1278963, 1278974, 1278985, 1278996, 1279009, 1279010, 1279021
ES	Centro de información online de medicamentos de la AEMPS	06372011, 06372019
LT	Valstybinė vaistų kontrolės tarnyba	1028313, 1028314, 1028315, 1028316, 1028317, 1028318, 1028319, 1028320, 1028321, 1028322, 1028323, 1028324, 1028325, 1028326, 1028327, 1028328, 1028329, 1028330, 1028331, 1028332, 1028333, 1028334, 1028335, 1028336, 1028337, 1028338, 1028339, 1028340, 1028341, 1028342, 1028343, 1028344, 1028345, 1056574, 1056575, 1056578, 1058737, 1058738, 1058739
NL	Z-Index G-Standaard, PRK	123471, 123498, 123501
PL	Rejestru Produktów Leczniczych	100176760, 100176776, 100176782
ZA	Health Products Regulatory Authority	45/7.1.3/0850, 45/7.1.3/0851, 45/7.1.3/1013, 45/7.1.3/1014